Follicular Lymphoma
Research results from Kings College update knowledge of follicular lymphoma
Published in Hospital Law Weekly, November 20th, 2008
" To compare the long-term outcome of patients with previously untreated follicular lymphoma (FL) needing therapy, after treatment with cyclophosphamide, vincristine and prednisone (CVP) versus CVP plus rituximab (R-CVP) and to evaluate the predictive value of known prognostic factors after treatment with R-CVP. Patients and Methods Patients with previously untreated CD20-positive stage III/ IV FL were randomly assigned to eight cycles of R-CVP (n = 159) or CVP alone (n = 162)," researchers in London, the United Kingdom report.
"The median follow-up period was 53 months. The primary end point-time to treatment failure (TTF), which included patients without a response...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
Source: Hospital Law Weekly (2008-11-20)
More Articles from Hospital Law Weekly
- Adverse Drug Reactions
New research on adverse drug reactions from Louisiana State University summarized - AHA Solutions, Inc.
The American Hospital Association Awards its Endorsement to Identity Force's Identity Protection, Compliance and Data Breach Solutions. - AtriCure, Inc.
AtriCure Announces Investigation by the Department of Justice - Culbert Healthcare Solutions
Norm Botsford Joins Culbert Healthcare Solutions' Strategic Services Team - Eastern Michigan University
EMU School of Nursing Injects Much Needed Help Into Nursing Shortage - Ferraro Law Firm
Ft. Lauderdale Jury Awards Couple over $3 Million in Secondhand Asbestos Exposure Case - More from this issue of Hospital Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
